Skip to main content
. 2014 Aug 6;3(3):101–106. doi: 10.5527/wjn.v3.i3.101

Table 1.

Characteristics of patients included (n = 668) and not included (n = 103) in the analysis

Measured walk and fall information (n = 668) Missing measured walk or fall information (n = 103)1 P value
Male (%) 61.2 45.6 0.003
Age (yr), mean ± SD 56.3.(14.1) 62.2 (14.1) < 0.001
Race (%) < 0.001
White 22.2 31.1
Black 63.6 45.6
Native American 0.5 1
Asian 10.9 12.6
Other (Native Hawaiian, other Pacific Islander, other) 2.8 9.7
ESRD vintage, yr, mean ± SD 5.0 (5.2) 4.4 (4.1) 0.24
Diabetes (%) 48.1 73.5 < 0.001
COPD (%) 7.5 11.8 0.14
Cancer (%) 7.7 9.8 0.46
CHF (%) 27.3 42.2 0.002
CAD/MI (%) 26 39.2 0.005
CVA/TIA (%) 9.3 15.7 0.047
PVD (%) 6.5 31.4 < 0.001
Other cardiac diseases (%) 23.9 43.1 < 0.001
KDQOL-CF score, mean ± SD 88.0 (16.3) 86.3 (18.2) 0.35
Hemoglobin, g/dL, mean ± SD 11.6 (1.3) 11.3 (1.3) 0.1
Assistive walking device (%) 19.5 91.7 < 0.001
History of recent fall(s) (%) 27.1 37.2 0.04
1

One patient lacked fall history information only; no physical performance information was obtained for 19 patients; and study coordinators reported that 83 patients were not able to walk 15 feet to perform the walk test. CAD: Coronary artery disease; CHF: Congestive heart failure; COPD: Chronic obstructive pulmonary disease; CVA: Cerebrovascular accident; ESRD: End-stage renal disease; KDQOL-CF: Kidney Disease Quality of Life-Cognitive Function; MI: Myocardial infarction; m/s: Meters per second; Other cardiac disease: Cardiac dysrhythmia, atrial fibrillation, tachycardia, pericarditis, cardiac arrest; PVD: Peripheral vascular disease; TIA: Transient ischemic attack.